AutoZone shares have crushed the S&P 500 in the past five years. The products this company sells register durable demand, ...
Zacks Investment Research on MSN
AutoZone, Inc. (AZO) is attracting investor attention: Here is what you should know
AutoZone (AZO) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...
AutoZone remains a defensive, all-weather compounder, now retracing after missing Q1 2026 revenue and EPS estimates. Read my ...
Guggenheim Securities: AutoZone made a "solid start to 2026," with U.S. commercial growth continuing to gain momentum, Forbes ...
Fintel on MSN
Wolfe Research downgrades AutoZone (AZO)
Fintel reports that on December 16, 2025, Wolfe Research downgraded their outlook for AutoZone (NYSE:AZO) from Outperform to ...
Analysts expect the company to report quarterly earnings at $32.51 per share, down from $32.52 per share in the year-ago ...
AutoZone Inc (AZO) reports an 8.2% sales increase and robust commercial growth, despite a dip in EPS due to LIFO charges.
Discover key takeaways from AutoZone's Q1 2026 earnings: strong sales growth, accelerated store expansion, margin impacts, ...
What do Azo products treat? Azo products are used to treat symptoms caused by urinary tract infections (UTIs). This can include pain and burning as well as urgency and frequency of peeing. Azo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback